Graham Parry is an experienced Senior European Pharmaceuticals/Healthcare Equity Analyst with a strong academic background in Biochemistry. He holds a Master's degree in Biochemistry from the University of Oxford. With over two decades of experience in the pharmaceutical and healthcare industry, Mr. Parry has worked with some of the leading financial institutions in the world. He is a former Global Healthcare Specialist sales at Merrill Lynch and European Pharmaceutical Equity Analyst at ABN AMRO Bank N.V. He has also worked as a European Biotechnology Equity Analyst at ABN AMRO Bank N.V. and as an Australian equity sales/sales trading at J.B. Were & Son.

Mr. Parry's expertise lies in the healthcare sector, and he has a keen understanding of pharmaceutical, biotechnology, and healthcare developments in Europe and globally. He provides clients with critical insight, analysis, and advice aimed at helping them navigate challenging market conditions. He has a strong grasp of healthcare regulations and can provide insightful guidance on the regulatory framework governing healthcare, biotech, and pharma companies.